11C-Methionine PET/CT Imaging in Patients Affected by Malignant Pleural Mesothelioma (MPM)
NCT02519049 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30
Last updated 2020-10-01
Summary
Prospective exploratory study specifically investigating the role of 11C-Methionine PET/CT imaging in patients affected by Malignant Pleural Mesothelioma (MPM) and candidate to pleurodesis.
Conditions
- Mesothelioma, Malignant
Interventions
- OTHER
-
No intervention
This is an observational study
Sponsors & Collaborators
-
Istituto Clinico Humanitas
lead OTHER
Principal Investigators
-
Egesta Lopci, MD · Humanitas Clinical and Research Hospital
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-09-30
- Primary Completion
- 2018-09-30
- Completion
- 2018-12-31
Countries
- Italy
Study Locations
More Related Trials
-
Tumor Metabolism of Lung Cancer in Patients Who Underwent Percutaneous Radiation Measured With F-18-FDG-PET
NCT00180154 ·Status: COMPLETED
-
Expanded Access [11C] Methionine PET Imaging
NCT05511714 ·Status: AVAILABLE
-
18F-FDG Metabolism Imaging Monitoring Non-small Cell Lung Cancer Curative Effect of Chemotherapy Multicenter Clinical Study
NCT02938546 ·Status: UNKNOWN ·Phase: PHASE3
-
FLT-PET/DW-MRI for Detection of Brain Metastases and Early Therapy Evaluation in Patients With Small Cell Lung Cancer
NCT02995902 ·Status: COMPLETED ·Phase: NA
-
18F-FDG and 68Ga-FAPI PET/CT in Lung Adenocarcinoma
NCT04588064 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Response by FLT PET in Mesothelioma
NCT06410625 ·Status: RECRUITING ·Phase: NA
-
Of 18F MEL050 Using PET/CT in Metastatic Melanoma
NCT01620749 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Clinical Study of CLDN18.2 PET/CT for Noninvasive Diagnosis of Gastric and Pancreatic Cancer
NCT06203613 ·Status: RECRUITING ·Phase: NA
-
Fluorine-18-α-Methyltyrosine Positron Emission Tomography (18F-FMT PET) for Therapy Response in Lung Cancer
NCT00826033 ·Status: COMPLETED
-
18F-FSPG PET/CT Imaging in Patients With Cancers
NCT03144622 ·Status: UNKNOWN
-
Comparative Study of the Hypoxia Measured in FAZA and F-miso PET/CT Scan in Patients With Non-small Cell Lung Cancer
NCT02490696 ·Status: COMPLETED ·Phase: PHASE2
-
18F-FSPG PET/CT for Cancer Patients on Therapy
NCT02599194 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Application of 18F-PFPN PET Imaging in Diagnosis and Staging of Clear Cell Sarcoma of Soft Tissue
NCT05963035 ·Status: UNKNOWN ·Phase: NA
-
An Efficacy and Safety Study to Assess [18F]-ML-10 in Detecting Response of Tumors to Chemotherapy and Radiation
NCT01260480 ·Status: UNKNOWN ·Phase: PHASE2
-
[18F]-DPA-714 PET/CT (Positron Emission Tomography/Computerized Tomography) in Triple Negative Breast Cancers
NCT04320030 ·Status: COMPLETED ·Phase: PHASE2
-
Methionine PET/CT Studies In Patients With Cancer
NCT00840047 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Clinical Evaluation of 18F-DOPA Positron Emission Tomography in Medullary Thyroid Cancer
NCT00647140 ·Status: TERMINATED ·Phase: PHASE2
-
68Ga-FAPI PET/CT in Patients With Various Types of Cancer
NCT04499365 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Application of Al18F-NOTA-FAPI PET/CT in Malignant Tumors Expressing Fibroblast-activated Proteins
NCT05749302 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
C11-Acetate PET/CT in Multiple Myeloma: Added Value to F18-Fluorodeoxyglucose PET/CT
NCT01691300 ·Status: COMPLETED ·Phase: NA
-
Role of Magnetic Resonance Enterography for Predicting Peritoneal Cancer Index
NCT05063019 ·Status: UNKNOWN ·Phase: NA
-
18F-mFBG PET Imaging in the Evaluation of Pheochromocytoma
NCT06813742 ·Status: RECRUITING
-
Evaluation of Prognosis With Integrated MRI/PET in Patients With Pancreatic Cancer
NCT02550847 ·Status: UNKNOWN
-
The Role of 18F-FDG&68Ga-FAPI PET/CT in the Assessment of Conversion Therapy Efficacy in Gastric Cancer with Peritoneal Metastasis.
NCT06597526 ·Status: RECRUITING
-
[18F]FLT PET/CT in Rb+ Metastatic Breast Cancer
NCT02608216 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1